Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

SFOSF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$13,524$13,694$16,241$10,308
Short-Term Investments$2,596$1,888$929$4,241
Receivables$9,430$9,697$8,172$6,474
Inventory$7,259$7,538$6,882$5,472
Other Curr. Assets$1,682$951$5,591$2,350
Total Curr. Assets$34,491$33,793$35,279$30,425
Property Plant & Equip (Net)$23,411$23,671$16,028$13,284
Goodwill$10,905$10,852$10,337$9,400
Intangibles$19,336$18,073$15,925$13,433
Long-Term Investments$23,269$25,560$24,621$19,679
Tax Assets$758$1,185$443$266
Other NC Assets$5,291$337$4,531$6,807
Total NC Assets$82,970$79,677$71,885$62,869
Other Assets$0$0$0$0
Total Assets$117,461$113,470$107,164$93,294
Liabilities
Payables$5,997$6,160$6,284$5,064
Short-Term Debt$18,711$14,728$11,932$14,548
Tax Payable$561$251$930$728
Deferred Revenue$0$0$1,545$8,170
Other Curr. Liab.$12,183$12,619$14,153$7,826
Total Curr. Liab.$37,453$33,758$33,298$29,310
LT Debt$12,985$15,555$12,845$9,697
Deferred Rev, NC$658$0$632$513
Deferred Tax Liab, NC$3,245$0$3,363$3,130
Other NC Liab.$3,186$7,541$3,038$2,268
Total NC Liab.$20,074$23,096$19,757$15,608
Other Liabilities$0$0$0$0
Cap. Leases$2,542$2,050$745$648
Total Liabilities$57,527$56,853$53,055$44,918
Equity
Pref Stock$0$0$0$0
Common Stock$2,671$2,672$2,672$2,563
Retained Earnings$26,553$24,543$26,170$21,040
AOCI$0-$1,300-$1,198$4,411
Other Equity$18,037$19,770$16,939$11,190
Total Equity$47,261$45,685$44,582$39,192
Supplemental Information
Minority Interest$12,673$10,931$9,526$9,184
Total Liab. & Tot. Equity$117,461$113,470$107,164$93,294
Net Debt$18,173$16,589$8,535$13,937
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Financial Statements & Key Stats | AlphaPilot